Drugs

Trial: Drug delays relapse in Alzheimer’s disease agitation … Study finds neflamapimod effective for dementia with Lewy bodies … Biogen shares trial data for tau-targeting Alzheimer’s drug …...

This month’s column invokes several previous columns, one about medications and the other about knowing if we know what we don’t know.  A recent medical journal article concluded that falls in...

Use of antipsychotic and psychoactive drugs following surgery generally fell in various settings among those experiencing postoperative delirium, according to a study published in the Journal of the American...

Healthcare workers including nurses and behavioral health workers have two times the risk for drug overdose compared to people who don’t work in the field, a new study shows.

Well, it looks like we have a good old fashioned war of words developing over Alzheimer’s drug coverage. It’s a battle well worth watching.

A number of pre-launch drugs are on track to address unmet patient needs in dementia, Parkinson’s disease and other ailments, say the authors of a 2023 report.

Seniors are willing to take their doctor’s advice to discontinue an unneeded medication after viewing an educational video, investigators say.

Clinicians appear to be relying on antiepileptics to address residents’ chronic pain and behavioral symptoms. Other drug prescriptions are meanwhile declining, MDS and Medicare data show.

Drug prescriptions increase in the 20 years before a patient’s dementia diagnosis, and prescribing patterns begin to hone in on particular medical conditions, a new study finds. 

The Stop-Falls-D program uses prompts to help reduce the use of drugs that affect the central nervous system, such as sleeping pills, anti-anxiety medications and pain relievers, in patients with dementia.